Pressure BioSciences, Inc. to Discuss 2009 Fourth Quarter and Full Year Financial Results and Provide Business Update

SOUTH EASTON, Mass., March 31, 2010 (GLOBE NEWSWIRE) -- Pressure BioSciences, Inc. (Nasdaq:PBIO) ("PBI" and the "Company") today announced that the Company will host a teleconference to discuss its 2009 fourth quarter and full year financial results and to provide a business update. Anyone interested may listen to the teleconference either by telephone or through a live web-cast. The teleconference and web-cast information is provided below:

Date: Wednesday March 31, 2010 Time: 4:30 p.m. Eastern Daylight Savings Time (EDT)

To attend this teleconference via web-cast, please go to the Company's website: www.pressurebiosciences.com

To attend this teleconference via telephone: Dial-in: (866) 834-4534 Conference ID: 66190910

For those unable to participate in the live teleconference, a replay will be available approximately one hour after the call ends through April 30, 2010 and will be accessible through the Company's website.

About Pressure BioSciences, Inc.

Pressure BioSciences, Inc. (PBI) is a publicly traded company focused on the development of a novel, enabling technology called Pressure Cycling Technology (PCT). PCT uses cycles of hydrostatic pressure between ambient and ultra-high levels (up to 35,000 psi and greater) to control bio-molecular interactions. PBI currently holds 14 US and 10 foreign patents covering multiple applications of PCT in the life sciences field, including genomic and proteomic sample preparation, pathogen inactivation, the control of chemical and enzymatic reactions, immunodiagnostics, and protein purification. PBI currently focuses its efforts in the development and sale of PCT-enhanced enzymatic digestion products designed specifically for the mass spectrometry marketplace, as well as sample preparation products for biomarker discovery, soil and plant biology, forensics, histology, and counter-bioterror applications.

CONTACT:  Pressure BioSciences, Inc.
          Investor Contacts:
          Richard T. Schumacher, President & CEO
          Joseph Damasio, Jr., Controller
          (508) 230-1828